Neurorehabilitation Devices Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care), and Geography

The neurorehabilitation devices market size is projected to reach US$ 7,086.82 million by 2031 from US$ 2,725.76 million in 2023. The market is expected to register a CAGR of 12.7% during 2023–2031. Technological advancements in neurorehabilitation devices are likely to bring new trends in the neurorehabilitation devices market in the coming years.

Neurorehabilitation Devices Market Analysis

The increasing number of survivors of traumatic brain injuries (TBI) who are seeking effective rehabilitation solutions boosts the demand for neurorehabilitation devices, favoring market growth. Additionally, technological advancements in neurorehabilitation, such as robotics and brain-computer interfaces, enhance treatment efficacy and patient engagement, fueling the growth of the neurorehabilitation devices market. The growing occurrence of neurological disorders and an elderly population further contribute to market expansion. Furthermore, a greater understanding of the benefits of early and personalized rehabilitation therapies encourages healthcare providers to adopt innovative neurorehabilitation devices, ultimately enhancing patient outcomes and quality of life.

Neurorehabilitation Devices Market Overview

The neurorehabilitation devices market is rapidly evolving, fueled by advancements in technology and an expanding demand for effective rehabilitation solutions. The rising incidence of strokes and other neurodegenerative disorders among the global population further propels the growth of the market. As per an article titled "Assessing the perception of Parkinson's disease in Al-Ahsa, Saudi Arabia among the visitors of a public campaign: before and after survey," published in April 2024, the prevalence of Parkinson's disease (PD) in Saudi Arabia has been estimated to be 27 per 100,000 population. With aging, the likelihood of developing neurodegenerative conditions increases. This necessitates a robust rehabilitation framework to address the distinctive challenges faced by these individuals, including mobility issues, balance problems, and cognitive decline. Neurorehabilitation devices play a crucial role in improving the quality of life for people suffering from PD. These devices can assist with physical therapy, improve motor skills, and provide cognitive training.

According to an article titled "Stroke care in MENA: challenges, progress, and promising pathways," published in May 2023, in the country, between 8,000 and 10,000 individuals experience a stroke annually. Neurorehabilitation devices are critical for stroke recovery, addressing motor impairments, leveraging innovative technologies, and enhancing patient engagement through immersive therapies. In addition, as healthcare providers increasingly adopt innovative solutions to enhance patient outcomes, the neurorehabilitation devices market is poised for significant growth in the future.

Neurorehabilitation Devices Market Drivers and Opportunities

Growing Number of Clinical Studies on Neurorehabilitation Devices

Clinical studies validate the safety and effectiveness of newly developed neurorehabilitation devices. They provide evidence that neurorehabilitation devices help enhance the quality of life of patients with neurological diseases. These studies encourage healthcare centers to integrate these devices into their treatment programs. For instance, "Clinical Study of a Wearable Remote Rehabilitation Training System for Patients with Stroke: Randomized Controlled Pilot Trial" was published in February 2023. The clinical study aimed to design a remote intelligent rehabilitation training system based on wearable devices and human-computer interaction training tasks and evaluate its safety and efficiency.

Researchers at the University of Kansas Medical Center are studying wearable technology as part of a national stroke recovery clinical trial. Experts are testing the effectiveness of wearable devices that stimulate electromagnetic energy in the brain and spinal cord, which may help decrease disability after a stroke.

In December 2022, a clinical trial study, "Effects of robotic rehabilitation using the Erigo device on patients with neurological injury: a systematic review and meta-analysis of randomized clinical trials," was published. The trial studied the effects of the Erigo robotic rehabilitation device on patients with neurological injury based on parameters such as safety, muscle strength, spasticity, functionality, gait/balance, and changes in the level of consciousness. The study concluded that Erigo, as a robotic rehabilitation device, is safe for patients with acquired brain injury and can reduce spasticity in patients with stroke. Thus, the increasing number of clinical studies on neurorehabilitation devices favors the growth of the market worldwide.

Strategic Initiatives by Market Players

Strategic initiatives taken by market players, such as mergers, acquisitions, partnerships, and collaborations, are likely to accelerate innovation, develop expertise, and expand market reach.

In April 2022, Blackrock Neurotech partnered with Phantom Neuro, a neurotech startup, to carry out research and development for Phantom Neuro's patent-pending Phantom X system, which offers patients highly accurate, almost real-time control of current and next-generation assistive devices, such as prosthetics and exoskeletons. This R&D partnership allows Phantom to use Blackrock's decades of experience in neurotechnology and develop biocompatible implantable sensors to bolster the Phantom X platform.

In December 2022, Ekso Bionics—a leader in exoskeleton technology for medical use—announced the acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation. This acquisition will enhance Ekso's product portfolio and improve its strategic relationships with commercial and research partners such as Vanderbilt University. The partnership with Vanderbilt is expected to enhance its research capabilities and product development.

Thus, the strategic initiatives taken by the market players are likely to create lucrative opportunities for the neurorehabilitation market in the near future.

Neurorehabilitation Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the neurorehabilitation devices market analysis are product type, application, and end user.

• Based on product type, the neurorehabilitation devices market is categorized into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the market in 2023.
• Based on application, the market is categorized into stroke, spinal cord injury, cerebral palsy, traumatic brain injury, Parkinson's disease, and others. The stroke segment held the largest neurorehabilitation devices market share in 2023.
• In terms of end user, the neurorehabilitation devices market is segmented into hospitals and clinics, rehabilitation centers, and home care. The hospitals and clinics segment dominated the market in 2023.

Neurorehabilitation Devices Market Share Analysis by Geography

The geographic scope of the neurorehabilitation devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America held a significant share of the market in 2023. The growth of the market is driven by the growing prevalence of neurological disorders, such as cerebral palsy and spinal cord injury, followed by the surging technological advancement in the field of neurorehabilitation devices. In addition, new product launches and increasing research and development for advancing neurorehabilitation devices are projected to accelerate the growth of the neurorehabilitation devices market in the region.

According to the Brain Injury Canada report, TBI is the leading cause of disability, with 2% of Canadians associated with 18,000 hospitalizations annually. According to the Brain Injury Association of Waterloo-Wellington, TBI occurs in 500 out of 100,000 people yearly in Canada; over 6,000 patients become permanently disabled each year due to a TBI. The integration of neurorehabilitation devices is a crucial part of the recovery process for TBI patients. These devices, including robotic systems and cognitive aids, facilitate targeted rehabilitation by providing personalized therapy that enhances motor skills and cognitive functions.

Neurorehabilitation Devices Market Regional Insights

The regional trends and factors influencing the Neurorehabilitation Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Neurorehabilitation Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Neurorehabilitation Devices Market Report Scope

Neurorehabilitation Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Neurorehabilitation Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Neurorehabilitation Devices Market are:

1. Blackrock Microsystems Inc
2. Hocoma AG
3. Medtronic Plc
4. Tyromotion GmbH
5. Ekso Bionics Holdings Inc
6. BIONIK

Disclaimer: The companies listed above are not ranked in any particular order.

Neurorehabilitation Devices Market News and Recent Developments

The neurorehabilitation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the neurorehabilitation devices market are listed below:

• Ekso Bionics Holdings, Inc. received 510(k) clearance from the US Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients. It is the first exoskeleton device to receive FDA clearance for rehabilitation in patients with multiple sclerosis. This indication significantly expands the device's use to a broader group of patients. In addition to its FDA clearances, EksoNR is CE-marked and available in Europe. (Source: Ekso Bionics Holdings, Inc., Press Release, June 2022)
• DIH, a leading global robotics and virtual reality (VR) technology company for advanced rehabilitation care, announced the shift of the strategic commercial agreement made in 2020 with Gorbel, Inc. into the complete purchase of its Rehabilitation Division. All three SafeGait devices will continue to be manufactured in the United States and are now listed with the FDA under DIH Technology, Inc. (Source: DIH, Press Release, October 2022)

Neurorehabilitation Devices Market Report Coverage and Deliverables

The "Neurorehabilitation Devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Neurorehabilitation devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Neurorehabilitation devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Neurorehabilitation devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the neurorehabilitation devices market
• Detailed company profiles

The List of Companies - Neurorehabilitation Devices Market

• Blackrock Microsystems Inc          
• Hocoma AG         
• Medtronic Plc       
• Tyromotion GmbH            
• Ekso Bionics Holdings Inc             
• BIONIK    
• Abbott Laboratories          
• Renishaw Plc       
• EMOTIV               
• BioXtreme Ltd.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurorehabilitation devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the neurorehabilitation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.